Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder

Internal Medicine

Volumn 51, Issue 7, 2012, Pages 809-812

  Niino, Masaaki ^a   Uesugi, Haruo ^b   Takahashi, Toshiyuki ^c   Fukazawa, Toshiyuki ^d   Minami, Naoya ^a   Tashiro, Jun ^a   Fujiki, Naoto ^a   Doi, Shizuki ^a   Kikuchi, Seiji ^a  

^a HOKKAIDO MEDICAL CENTER   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Sapporo Neurology Clinic   (Japan)

Author keywords

Anti aquaporin 4 antibody; Brainstem; Cerebrospinal fluid; Magnetic resonance imaging; Neuromyelitis optica; Spinal cord

Indexed keywords

AQUAPORIN 4 ANTIBODY; GADOLINIUM; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; PREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN STEM INJURY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CERVICAL SPINAL CORD INJURY; DRUG DOSE REDUCTION; FEMALE; HEMIPARESIS; HUMAN; HYPERREFLEXIA; LOW DRUG DOSE; MUSCLE SPASM; MUSCLE WEAKNESS; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; RECURRENT DISEASE; SPASTICITY;

AGED; AGED, 80 AND OVER; AQUAPORIN 4; AUTOANTIBODIES; BRAIN STEM; BRAIN STEM INFARCTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA; RECURRENCE;

EID: 84859295423     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6351     Document Type: Article

References (6)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitisoptica: distinction from multiple sclerosis. Lancet 364: 2106-2112, 2004.
2. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815, 2007.
3. Nagaishi A, Takagi M, Umemura A, et al. Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes. J Neurol Neurosurg Psychiatry 82: 1360-1364, 2011.
4. Yanagawa K, Kawachi I, Toyoshima Y, et al. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology 73: 1628-1637, 2009.
5. Bedi GS, Brown AD, Delgado SR, Usmani N, Lam BL, Sheremata WA. Impact of rituximab on relapse rate and disability in neuromyelitis optica. Mult Scler 17: 1225-1230, 2011.
6. Popescu BF, Lennon VA, Parisi JE, et al. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 76: 1229-1237, 2011.